Description
This assay uses the Luminex® 200™ platform.
Consider this assay for a comprehensive analysis of 7 biomarkers associated with cardiovascular disease in mouse models. The Mouse Cardiovascular Disease Panel 1 7-Plex Discovery Assay® Array (MDCVD1) includes ProMMP-9, PAI-1 (Total), Pecam-1, sP-Selectin, sE-Selectin, sICAM-1, and Thrombomodulin.
This panel is designed to provide detailed insights into cardiovascular disease mechanisms by measuring critical markers involved in inflammation, endothelial function, and thrombotic processes. It is particularly useful for studying conditions like atherosclerosis, thrombosis, and endothelial dysfunction.
The assay offers robust performance with minimal sample volume requirements, making it an excellent choice for high-throughput studies in cardiovascular research.
For a more comprehensive immune profile, consider running the Mouse Cytokine/Chemokine 32-Plex Discovery Assay® Array (MD32) in addition to this assay. The MD32 is our most popular mouse array, providing an extensive cytokine and chemokine profile by measuring 32 biomarkers simultaneously from a small sample volume. This array includes key markers such as IL-6, TNFα, and VEGF-A, offering a broad view of immune responses and inflammatory pathways. Combining these assays will give you a more detailed and holistic understanding of the immune landscape in your mouse models.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
If your sample volume is limited, please contact us.
Click here for information on shipping biological samples for Discovery Assays
Published Research Featuring Our MDCVD1:
- Maus, M., López-Polo, V., Mateo, L., Lafarga, M., Aguilera, M., De Lama, E., Meyer, K., Sola, A., Lopez-Martinez, C., López-Alonso, I., Guasch-Piqueras, M., Hernandez-Gonzalez, F., Chaib, S., Rovira, M., Sanchez, M., Faner, R., Agusti, A., Diéguez-Hurtado, R., Ortega, S., Manonelles, A., Engelhardt, S., Monteiro, F., Stephan-Otto Attolini, C., Prats, N., Albaiceta, G., Cruzado, J. M., & Serrano, M. (2023). Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype. Nature Metabolism, 5(12), 2111–2130.
- Opichka, M. A., Livergood, M. C., Balapattabi, K., Ritter, M. L., Brozoski, D. T., Wackman, K. K., Lu, K.-T., Kozak, K. N., Wells, C., & Grobe, J. L. (2023). Mitochondrial-targeted antioxidant attenuates preeclampsia-like phenotypes induced by syncytiotrophoblast-specific Gαq signaling. Science Advances, 9(48), Article eadg8118.